HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
31.38 USD
+0.15 (+0.48%)
31.59 USD
+0.21 (+0.67%)
HIMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
- HIMS had positive earnings in the past year.
- HIMS had a positive operating cash flow in the past year.
- HIMS had negative earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS has a Return On Assets of 5.99%. This is amongst the best in the industry. HIMS outperforms 83.00% of its industry peers.
- HIMS has a better Return On Equity (23.03%) than 91.00% of its industry peers.
- The Return On Invested Capital of HIMS (5.84%) is better than 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 6.05%, HIMS belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
- The Operating Margin of HIMS (5.96%) is better than 66.00% of its industry peers.
- HIMS has a better Gross Margin (75.01%) than 90.00% of its industry peers.
- In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HIMS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HIMS has more shares outstanding
- HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- HIMS has an Altman-Z score of 3.91. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 3.91, HIMS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- HIMS has a Debt to FCF ratio of 8.13. This is comparable to the rest of the industry: HIMS outperforms 53.00% of its industry peers.
- A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.67, HIMS is doing worse than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 3.91 |
ROIC/WACC0.65
WACC9.02%
2.3 Liquidity
- HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 77.00% of its industry peers.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 67.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.73% over the past year.
- The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
- The Revenue has grown by 78.02% in the past year. This is a very strong growth!
- HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
- The Earnings Per Share is expected to grow by 28.57% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 22.77% on average over the next years. This is a very strong growth
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.54%
Revenue Next 3Y31.01%
Revenue Next 5Y22.77%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 58.11, which means the current valuation is very expensive for HIMS.
- HIMS's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.47, HIMS is valued quite expensively.
- HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 52.37.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (24.26), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.11 | ||
| Fwd PE | 52.37 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
- The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.79 | ||
| EV/EBITDA | 41.32 |
4.3 Compensation for Growth
- The decent profitability rating of HIMS may justify a higher PE ratio.
- A more expensive valuation may be justified as HIMS's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
31.38
+0.15 (+0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners94.2%
Inst Owner Change0.07%
Ins Owners5.93%
Ins Owner Change-3.31%
Market Cap7.14B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target44.47 (41.71%)
Short Float %31.63%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.45%
PT rev (3m)-10.71%
EPS NQ rev (1m)17.42%
EPS NQ rev (3m)-78.62%
EPS NY rev (1m)-3.6%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.11 | ||
| Fwd PE | 52.37 | ||
| P/S | 3.23 | ||
| P/FCF | 59.79 | ||
| P/OCF | 21.98 | ||
| P/B | 12.3 | ||
| P/tB | 56.33 | ||
| EV/EBITDA | 41.32 |
EPS(TTM)0.54
EY1.72%
EPS(NY)0.6
Fwd EY1.91%
FCF(TTM)0.52
FCFY1.67%
OCF(TTM)1.43
OCFY4.55%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.96
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 3.91 |
F-Score3
WACC9.02%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.54%
Revenue Next 3Y31.01%
Revenue Next 5Y22.77%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 4 / 10.